This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Colonaryconcepts LLC. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Kevin Douglass: Innovator in PEG Metabolite Assays
Introduction
Kevin Douglass is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods for analyzing polyethylene glycol (PEG) metabolites. With a total of 2 patents, Douglass continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Douglass's latest patents focus on "Compounds and methods for PEG metabolite and PEG breakdown product assays." These patents disclose innovative compounds and methods for identifying and quantifying metabolites or breakdown products of PEG. The assays utilize liquid chromatography combined with mass spectrometry to analyze samples for PEG metabolites or breakdown products. The process involves the derivatization of PEG metabolites or breakdown products within the sample using pentafluorobenzoyl chloride, optimizing the assay through negative chemical ionization mode liquid chromatography.
Career Highlights
Kevin Douglass is associated with Colonary Concepts LLC, where he applies his expertise in biochemistry to develop advanced analytical methods. His work has garnered attention for its potential applications in various fields, including pharmaceuticals and environmental science.
Collaborations
Douglass collaborates with talented individuals such as David Humphries and Beauregard Mason, contributing to a dynamic work environment that fosters innovation and creativity.
Conclusion
Kevin Douglass stands out as an inventor dedicated to advancing the understanding of PEG metabolites through his innovative patents and collaborative efforts. His work continues to have a meaningful impact in the field of biochemistry.